TY - JOUR T1 - Using Google Health Trends to investigate COVID-19 incidence in Africa JF - medRxiv DO - 10.1101/2021.03.26.21254369 SP - 2021.03.26.21254369 AU - Alexander Fulk AU - Daniel Romero-Alvarez AU - Qays Abu-Saymeh AU - Jarron M. Saint Onge AU - A. Townsend Peterson AU - Folashade B. Agusto Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/03/29/2021.03.26.21254369.abstract N2 - Objectives In the present manuscript we used Internet-derived data to assess whether Google Health Trends (GHT) search counts are able to track COVID-19 incidences in Africa.Methods We collected COVID-19 case and death incidence for 54 African countries from February 2020 to January 2021. We used GHT to characterize COVID-19 incidence up to 24 January 2021, collecting the number of searches of four terms: ‘coronavirus’, ‘coronavirus symptoms’, ‘COVID19’, and ‘pandemic’. The terms were related to weekly COVID-19 case incidences for the study period via multiple linear regressions. We also collected 72 predictors assessing Internet accessibility, demographics, economics, etc., to explain the potential mechanisms linking the relationship between GHT searches and COVID-19.Results Important increases for COVID-19 death incidence were observed for South Africa and Tunisia at the end of the study period. Our study demonstrated a lack of correlation between GHT and COVID-19 incidence for most African countries. The predictors analyzed were unhelpful in explaining the pattern of GHT statistics and their relationship to COVID-19, complicating interpretability of GHT.Conclusions According to our results, GHT-based surveillance for an ongoing epidemic might be useful only in specific situations. Future studies might assess the algorithm in different epidemic contexts.Competing Interest StatementThe authors have declared no competing interest.Funding StatementOur research is supported by the National Science Foundation with the grant number DMS 2028297.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The current manuscript does not need IRB or other committee board approval.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available as a supplementary material in the current submission. ER -